Treatment decisions should always be individualised after clinical evaluation and should follow current evidence-based recommendations
People sometimes worry about semaglutide affecting performance at work and whether that could draw scrutiny
All products and medications are manufactured and distributed by independent, third-party vendor pharmacies and are routinely inspected by both state and federal agencies for safety and efficacy
In most cases, GLP-1 receptor agonists will be prescribed for weight loss if either of the following apply to you : a BMI of 30 or more a BMI over 27 and you have a weight-related health condition, such as high blood pressure, high blood fat levels, or obstructive sleep apnoea GLP-1 agonists for weight loss will not be prescribed to you if you are not overweight or obese
Where Evidence Is Thin For fat loss, metabolism boosting, and detox, evidence is not strong enough to promise consistent results across people